From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...
MedPage Today on MSN
A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy
Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...
TipRanks on MSN
Pfizer’s New Bladder Cancer Study: A Potential Game-Changer?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical study titled A PHASE 1, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
A blood test for more than 50 types of cancer could help speed up diagnosis, according to a new study. Results of a trial in ...
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback